CSL Behring Reports - Industry Research
Reports Featuring CSL Behring
Plasma Fractionation Market
The plasma fractionation market studied is anticipated to grow with a CAGR of nearly 8.76% during the forecast period.
Anti-venom Market
The anti-venom market is expected to register a CAGR of nearly 8.54% during the forecast period.
Influenza Vaccine Market
The Influenza Vaccine Market is expected to register a CAGR of 5.65% during the forecast period.
Plasma Protein Therapeutics Market
The plasma protein therapeutics market has been projected to register a CAGR of 5.3% over the forecast period.
Pneumococcal Vaccines Market
The Pneumococcal Vaccines Market size is estimated at USD 8.80 billion in 2024, and is expected to reach USD 11.20 billion by 2029, growing at a CAGR of 4.83% during the forecast period (2024-2029).
Immunoglobulin Market
The Global Immunoglobulin Market size is expected to grow from USD 14,482.11 million in 2023 to USD 20,607.86 million by 2028, at a CAGR of 7.31% during the forecast period.
Global Guillain-Barre Syndrome Market
The Guillain-Barre Syndrome Market studied is anticipated to grow at a CAGR of 5.2% during the forecast period, 2022-2027.
Intravenous Iron Drugs Market
The intravenous iron drugs market is expected to grow at a significant CAGR of 8.35% during the forecast period.
Hemostasis Products Market
The Hemostasis products market is expected to witness a CAGR of 5.2% during the forecast period (2022-2027).
Global Tissue Sealants Market
The tissue sealants market is expected to register a CAGR of 7% during the forecast period.
.
Rare Neurological Disease Treatment Market
The Rare Neurological Disease Treatment Market is expected to register a CAGR of 8.6% during the forecast period.
Global Hereditary Angioedema Therapeutics Market
The hereditary angioedema therapeutics market is expected to register a CAGR of 8.5% during the forecast period.
Global Fibrinogen Concentrate Market
The fibrinogen concentrate market is expected to register a healthy CAGR of 5.8% during the forecast period (2022-2027).
Von Willebrand Disease Treatment Market
The Von Willebrand disease (VWD) treatment market is expected to register a CAGR of 6.5% during the forecast period.
Hyperkalemia Treatment Market
The hyperkalemia treatment market is poised to register a CAGR of 16.79% over the forecast period.
Antithrombin Market
The antithrombin market is expected to register a CAGR of 4.3% over the forecast period.
Anticoagulant Reversal Drugs Market
The anticoagulant reversal drugs market is expected to witness a CAGR of 12.01% over the forecast period.
Global Primary Immunodeficiency Therapeutics Market
The Primary Immunodeficiency Therapeutics Market is expected to register a CAGR of 6.1% during the forecast period.
Subcutaneous Immunoglobulin Market
The subcutaneous immunoglobulin market studied was projected to grow with a CAGR of nearly 13.3% over the forecast period.
Blood Disorder Therapeutics Market
The Blood Disorder Therapeutics Market is expected to register a CAGR of 6.2% during the forecast period.
Plasma Protease C1-inhibitor Market
The Plasma Protease C1-inhibitor Treatment Market is expected to experience a significant growth over the forecast period due to the growing incidence of hereditary angioedema (HAE).
H1N1 Vaccines Market
The H1N1 Vaccines Market is expected to register a CAGR of 5.2% during the forecast period.
Other Reports Covering CSL Behring
Pharmaceuticals
- Albumin Market
- Anti-venom Market
- Anticoagulant Reversal Drugs Market
- Antithrombin Market
- Australia Pharmaceuticals Market
- Biobetters Market
- Blood Disorder Therapeutics Market
- Global Guillain-Barre Syndrome Market
- Global Hereditary Angioedema Therapeutics Market
- Global Intravenous Immunoglobulin Market
- Global Primary Immunodeficiency Therapeutics Market
- Global Rare Hemophilia Factors Market
- H1N1 Vaccines Market
- Hyperkalemia Treatment Market
- Immunoglobulin Market
- Influenza Vaccine Market
- Intravenous Iron Drugs Market
- Pneumococcal Vaccines Market
- Rare Neurological Disease Treatment Market
- Subcutaneous Immunoglobulin Market
- Thrombin Market
- Vaccine Adjuvants Market
- Von Willebrand Disease Treatment Market
Industries CSL Behring Operates Within:
General Pharmaceuticals Companies
- Europe General Pharmaceuticals Companies
- Middle East and Africa General Pharmaceuticals Companies
- South America General Pharmaceuticals Companies
- Europe General Pharmaceuticals Companies
- Middle East and Africa General Pharmaceuticals Companies
- North America General Pharmaceuticals Companies
- South America General Pharmaceuticals Companies
